Author: Bo Ram Beck; Bonggun Shin; Yoonjung Choi; Sungsoo Park; Keunsoo Kang
Title: Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model Document date: 2020_2_2
ID: cszqykpu_1
Snippet: Coronaviruses (CoVs), belonging to the family Coronaviridae, are positive-sense enveloped RNA viruses and cause infections in birds, mammals, and humans (1) (2) (3) . The family includes four genera, such as Alphacoronavirus, Betacoronavirus, Deltacoronavirus, and Gammacoronavirus (4) . Two infamous infectious coronaviruses in the genus Betacoronavirus are severe acute respiratory syndrome coronavirus (SARS-CoV) (5) and Middle East respiratory sy.....
Document: Coronaviruses (CoVs), belonging to the family Coronaviridae, are positive-sense enveloped RNA viruses and cause infections in birds, mammals, and humans (1) (2) (3) . The family includes four genera, such as Alphacoronavirus, Betacoronavirus, Deltacoronavirus, and Gammacoronavirus (4) . Two infamous infectious coronaviruses in the genus Betacoronavirus are severe acute respiratory syndrome coronavirus (SARS-CoV) (5) and Middle East respiratory syndrome coronavirus (MERS-CoV) (6) , which have infected more than 10,000 people around the world in the past two decades. Unfortunately, the incidence was accompanied by high mortality rates (9.6% for SARS-CoV and 34.4% for MERS-CoV), indicating that there is an urgent need for effective treatment at the beginning of the outbreak to prevent the spread (7, 8) . However, this cannot be achieved with current drug development or an application system, taking several years for newly developed drugs to come to the market.
Search related documents:
Co phrase search for related documents- application system and MERS CoV: 1
- application system and MERS CoV SARS CoV: 1
- application system and mortality rate: 1, 2, 3
- application system and RNA virus: 1, 2, 3, 4
- application system and SARS CoV: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
- application system and urgent need: 1, 2, 3, 4, 5
- application system and world people: 1
- current drug development and drug development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57
- current drug development and effective treatment: 1, 2
- current drug development and past decade: 1
- current drug development and SARS CoV: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- current drug development and urgent need: 1, 2, 3, 4, 5, 6, 7, 8
- drug development and effective treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- drug development and high mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- drug development and MERS CoV: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67
- drug development and MERS CoV SARS CoV: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44
- drug development and mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- drug development and outbreak beginning: 1, 2, 3
- drug development and past decade: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
Co phrase search for related documents, hyperlinks ordered by date